Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples.
about
Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumannii in Birmingham, EnglandPCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patientsAnalysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems.Rapid detection of methicillin resistance in coagulase-negative Staphylococci with the VITEK 2 system.Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.Acinetobacter baumannii: emergence of a successful pathogenReal-time fluorescence loop mediated isothermal amplification for the detection of Acinetobacter baumannii.Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.Use of 16S rRNA gene for identification of a broad range of clinically relevant bacterial pathogens.Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli.Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.Use of positive blood cultures for direct identification and susceptibility testing with the vitek 2 system.Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card.Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance.Evaluation of a fully automated system (RAISUS) for rapid identification and antimicrobial susceptibility testing of Staphylococci.Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex.Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods.Antifungal susceptibility profile of diferent yeasts isolates from wild animals, cow's milk with subclinical mastitis and hospital environment.In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.Validation of Vitek 2 nonfermenting gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting gram-negative rods from patients with cystic fibrosis.Nonfermenters under the influence: ethanol disinfection of a saline dispenser caused misidentification by the Vitek 2 system using the new GN cards.Rapid identification and antimicrobial susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 system.Molecular epidemiology of carbapenem-resistant Acinetobacter spp. from XiangYa Hospital, in Hunan Province, China.Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles.
P2860
Q21146626-A2F70651-EE3C-402B-B990-7338C522EDF3Q33715997-5BD36535-F4D9-4DD5-93F1-2358C824AD29Q34041896-B59CABFD-38BC-4AD4-8273-02F57FBA8CA9Q34196138-F2E9541A-03A4-44DD-B092-E17BA26DD52FQ34431957-ABCFB4EB-7368-4F7C-AAF8-69D30D55822AQ34795807-F17A27D6-D95D-4988-AE7C-F629DB2CFFBFQ34812152-C16CCF0A-CBD5-4287-A5AB-392694867B6DQ34956792-E3D102E9-399E-4EC0-89C5-0A9E8FE10AB1Q34991064-E0B6D6BB-14DD-4C3E-AB61-2FB599CC995BQ35058071-E4DAE7A7-E5FF-4ED6-B8DC-768EA1F2D1C3Q35220822-4595EC91-1410-484A-BA80-763D643FB3E5Q36011374-580BBBC9-F15A-40C0-9345-1CF6FBC011DAQ37419949-52FF1483-C261-49A1-8048-6E049AC35CF0Q38627303-202A20F5-68B8-4E3E-A082-8ABD6BDEF882Q39487540-E166E41A-2E76-4169-8933-AF09DBF3B905Q39751239-31F0A840-3A47-42DD-9EBF-A0F5246ACF5AQ39760823-DD2E2EC7-A450-485B-8955-2620B0B50A74Q39804876-C48D8288-C708-4FDB-A8DB-C3C1F400FA14Q39900652-3AF315F1-C784-45CF-9FB0-34C1A5FF5284Q39990198-602CDB87-B84B-4D88-B782-5E9FA1F21CEBQ40138382-885C18A8-EDEF-45DB-AF09-69F780218432Q41762176-FC27DEF5-435D-4E17-B91C-8C78CB0E6AD0Q41976892-127B092B-8D6F-46AC-9F2E-6F522884205CQ42080315-93557714-F7C5-40C6-93E8-78E235D6E446Q42948531-AA53FF6F-7C68-42F3-A758-67514A2315AFQ44290539-B7DD0146-877F-4B8F-BEB4-4F018A5ECE26Q45109252-43D53100-AD04-41A2-915F-57BF7F64B23C
P2860
Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Evaluation of the VITEK 2 syst ...... solated from clinical samples.
@en
Evaluation of the VITEK 2 syst ...... solated from clinical samples.
@nl
type
label
Evaluation of the VITEK 2 syst ...... solated from clinical samples.
@en
Evaluation of the VITEK 2 syst ...... solated from clinical samples.
@nl
prefLabel
Evaluation of the VITEK 2 syst ...... solated from clinical samples.
@en
Evaluation of the VITEK 2 syst ...... solated from clinical samples.
@nl
P2093
P2860
P1476
Evaluation of the VITEK 2 syst ...... isolated from clinical samples
@en
P2093
M del Carmen Conejo
P2860
P304
P356
10.1128/JCM.39.9.3247-3253.2001
P407
P577
2001-09-01T00:00:00Z